This site uses cookies for analytics and to improve your experience. By clicking Accept, you consent to our use of cookies. Learn more in our privacy policy.
Healthtech supply chains are under new pressure from tariffs, traceability requirements, geopolitical risk and sustainability expectations. For leaders in medical devices, biopharma and diagnostics, resilience increasingly means building flexible, transparent supply networks that can adapt without compromising quality, access or long-term value.